BioCardia
BCDA
20 hedge funds and large institutions have $812K invested in BioCardia in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
47% more capital invested
Capital invested by funds: $552K → $812K (+$260K)
11% more funds holding
Funds holding: 18 → 20 (+2)
1.23% less ownership
Funds ownership: 7.35% → 6.12% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$128K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$78.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$37K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$15.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$24.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$8.58K |
| 3 |
Citigroup
New York
|
-$1.07K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$83 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$1 |
BCDA Hedge Fund Activity: Q4 2025 in Review
20 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2025, worth a combined $812K — up 47% from $552K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCDA positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $128K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $24.9K sold.
- 20 institutional investors held BioCardia (BCDA) as of Q4 2025, up from 18 in Q3 2025.
- Funds reported $812K of BioCardia stock for Q4 2025, up 47% quarter-over-quarter.
- 4 funds opened new BioCardia positions in Q4 2025 and 2 closed out, a net change of +2 holders.
- The largest BioCardia buyer in Q4 2025 was Citadel Advisors, an estimated $128K added.
- The largest BioCardia seller in Q4 2025 was Two Sigma Securities, an estimated $24.9K sold.
Based on aggregated 13F filings for Q4 2025.